canakinumab - Generic Medications

Browse 1 brand name versions of canakinumab. Review brand names, dosage forms, strengths, and linked product records.

Ilaris CANAKINUMAB
(CANAKINUMAB) 150 mg/ml Injection
NOVARTIS PHARMACEUTICALS CORPORATION FDA Rx Only

Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs to the IgG1/κ isotype subclass. It is expressed in a murine Sp2/0-Ag14 cell line and comprised of two 447- (or 448-) residue heavy chains and two 214-residue light chains, with a molecular mass of 145157 Daltons when deglycosylated. Both heavy chains of canakinumab contain oligosaccharide chains linked to the protein backbone at asparagine 298 (Asn 298). The biological activity of canakinumab is measured by comparing its inhibition of IL-1β-dependent expression of the reporter gene luciferase to that of a canakinumab internal reference standard, using a stably transfected cell line. ILARIS Injection ILARIS (canakinumab) Injection is supplied as a sterile, preservative-free, clear to opalescent, colorless to slightly brownish-yellow solution for subcutaneous injection in a single-dose, glass vial with coated stopper and aluminum flip-off cap. Each vial delivers 1 mL containing 150 mg canakinumab, L-histidine (2.1 mg), L-histidine HCl monohydrate (1.3 mg), mannitol (49.2 mg), polysorbate 80 (0.4 mg), and Sterile Water for Injection.

About canakinumab Generic Drugs

This collection groups medications in our database under the generic name canakinumab. It currently includes 1 matching listing.

What You Can Review

Use this page to compare the set of products we have indexed for this generic name. Each result links to more detailed product information and related landing pages.

Safety Information

Always consult a qualified healthcare professional before starting, stopping, or switching any medication. The information on this page is educational and should not replace medical advice.

Medical Tools & Resources

← Back to search